BIRAONE is an oral hormonal therapy used in the treatment of metastatic castration-resistant prostate cancer. It contains abiraterone acetate, which blocks the enzyme CYP17 to inhibit androgen production, a key driver of prostate cancer. BIRAONE is used in combination with prednisone tablets and has demonstrated improved survival in patients with advanced disease.

LUPROSON injection is used in advanced prostate Cancer which helps in lowering testosterone levels, which can slow the growth of prostate cancer cells.

FULVESON injection is used in metastatic breast cancer women with disease progression following antioestrogen therapy.

MEGECET oral suspension 120ml/240ml contains the active substance Megestrol. It belongs to a category of medications called progestogens.